Navigation Links
Clinilabs Launches Research Volunteer Authentication Initiative Choosing Verified Clinical Trials to Stop Dual Enrollment in Clinical Trials
Date:4/2/2013

New York, NY (PRWEB) April 02, 2013

Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, today announced that it has launched a subject authentication initiative at its Phase 1 sites in New York and New Jersey. This initiative includes the authentication of subject identity and medical history, background checks, and tracking of prior study participation in order to eliminate ineligible subjects from clinical trials. The Company has selected Verified Clinical Trials (VCT) to assist with this initiative, implementing the VCT clinical trials database registry system. VCT’s registry is designed to stop the professional research subjec t from enrolling in multiple clinical trials simultaneously – a situation known as dual enrollment. This collaboration between Clinilabs and VCT is a reflection of both companies’ commitment to volunteer safety and data quality.

Failure to document the identity of study volunteers, inaccuracies in subjects’ medical histories, and multiple concurrent enrollments have become a serious problem in the clinical research world. Study volunteers interested in free care or compensation may present inaccurate information in order to gain entry to clinical trials, and some may jump from one study to another without waiting for enough time to lapse between treatments. This type of research volunteer places everyone at risk including the drug manufacturer, the research site, and most importantly, themselves, potentially jeopardizing their health. Furthermore, this may compromise data quality.

Clinilabs and Verified Clinical Trials are determined to meet the challenge of subject enrollment in a proactive way, ensuring that only eligible subjects are enrolled in clinical trials. Dr. Gary Zammit, President and CEO states, "Most of us in the industry recognize the existence and the significant ramifications of improper enrollment in clinical trials, but we have never before been able to quantify it, detect it, or stop it. Clinilabs has taken the lead among CROs to provide its clients with a thoughtfully-conceived approach to subject authentication – ensuring the accuracy and integrity of volunteer data."

Dr. Mitchell Efros, CEO of Verified Clinical Trials states, "Clinilabs has joined an impressive cohort of companies on a local and national level to improve the quality of their trials. The recognition of dual enrollment in clinical research and use of the VCT system has literally exploded as of late". Dr. Efros adds, "We are very excited to have a company like Clinilabs join our expansive network that includes and focuses on both early and late phase trials. Clinilabs has joined the largest clinical research database network across North America and only strengthens this cooperative registry."

About Clinilabs Inc.

Clinilabs is a full-service contract research organization (CRO) that specializes in early-phase studies, from first-in-human to proof-of-concept, with normal healthy volunteers and patient populations. The company owns and operates two Phase I units in the US, and maintains a network of highly qualified investigator sites for multicenter Phase II studies Worldwide. Specialty projects, including pharmacodynamic, biomarker, cardiac safety, sleep/wakefulness, metabolic, and Japanese bridging are among our strengths. Clinilabs is recognized globally as a leading specialty CRO, offering an alternative to large CRO for specialty projects. For more information, please visit http://www.clinilabs.com.

About Verified Clinical Trials

Verified Clinical Trials is a forward thinking company developed by experts active in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers numerous other value added services to the clinical research site, CRO, and Pharmaceutical Sponsor, that prove invaluable with regards to financial and legal issues and liabilities. For more information, visit http://www.verifiedclinicaltrials.com.

Clinilabs Contact:
Hannah D’Aoust
Phone: (646) 215-6480
hdaoust(at)clinilabs(dot)com

Verified Clinical Trials Contact:
Kerri Weingard ANP
Chief Operating Officer
Phone: (516) 998-7499
kweingard(at)verifiedclinicaltrials(dot)com

Read the full story at http://www.prweb.com/releases/ClinilabsVerifiedClinical/StopDualEnrollment/prweb10587136.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst
2. Neighborhood Smiles Launches a Groundbreaking Cavity Prevention Program for Their Patients
3. Dr. Timothy Rauch of Albuquerque, New Mexico Launches a Groundbreaking Cavity Prevention Program
4. CellHealth Institute Launches with Support from Influential Investors
5. Dr. Richard Charmoy Launches Groundbreaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
6. Elsevier Launches Web-Based Pathway Studio and Adds New Molecular Data from Its Biology Journals to Boost Early Discovery Research
7. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
8. Rockingham County Economic Development Launches New Website
9. Neogen launches rapid tests for ractopamine
10. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
11. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... 2016 , ... Shimadzu Scientific Instruments will showcase several new ... poster sessions, and present on the analysis of mycotoxins and medical cannabis at ... 10 at the Georgia World Congress Center in Atlanta, Georgia. , Attendees ...
(Date:2/4/2016)... , Feb. 4, 2016 Beike Biotechnology, the ... medical institutions attended a ceremony in late 2015 to ... cell therapy in 2016. --> ... Translation Platform for Personalized Cell Therapy" was hosted by ... Production Center, both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... VANCOUVER, British Columbia and MENLO PARK, ... Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies, today announced that it will present at the ... on Monday, February 8, 2016 at 10:00 a.m. EST in ... Jeffrey Bacha , DelMar,s president and CEO, will provide an ...
(Date:2/4/2016)... 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... to be held February 8-9, 2016, at the Waldorf ... Growth & Healthcare Conference, taking place in ... James Sapirstein , Chief Executive Officer of ContraVir, ...
Breaking Biology Technology:
(Date:1/8/2016)... and MANCHESTER, United Kingdom , Jan. ... developer of innovative sensor-based diagnostic products, today announced the closing ... new and existing investors.  Proceeds from the financing will be ... , a hand-held device for detecting early-stage pressure ulcers. ... Ireland after receiving CE Mark approval. The device,s ...
(Date:1/7/2016)... NEW YORK , Jan. 7, 2016 ... as regional markets for biometric technologies and devices, identifying ... application market for various types of biometric devices. Includes ... report to: Identify newer markets and explore the ... of biometric devices. Examine each type of biometric technology, ...
(Date:1/7/2016)... , Jan. 7, 2016  A United States ... the first court in the country to interpret a ... lawsuit to go forward against the photo website Shutterfly ... BRIAN NORBERG vs. SHUTTERFLY, INC.; and ... plaintiff alleges that Shutterfly violates the Illinois Biometric Privacy ...
Breaking Biology News(10 mins):